Keyword: COPD

COPD can be genetic. So Wednesday, on Rare Disease Day, Grifols is launching an awareness campaign to encourage COPD patients to get tested.

Novartis is denying a report out of India suggesting it may be looking to retreat from the increasingly competitive market for asthma and COPD drugs and is seeking to sell off some brands—or even divest its entire portfolio.

How does incoming GSK chief Emma Walmsley view the generic threat to Advair—and its potential hit to Glaxo's financials? Investors will get a clue this week.

Coming on the heels of announcing a study to test a device focused on helping Parkinson’s patients, French drug delivery company Biocorp has unveiled its newest sensor that connects inhalers to devices like smartphones and tablets for people suffering from asthma or COPD.

COPD sales in China for AstraZeneca will remain strong as the number of nebulizer centers expands in the country.